Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic ...
Evidence for the environmental factor is seen in drug-induced systemic lupus erythematosus (SLE) and silica-induced scleroderma-like disease (predominant among men), and toxin-induced scleroderma ...
The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...
The intricate interplay between redox signaling and inflammation lies at the core of numerous pathologies, ranging from chronic inflammatory disorders to acute tissue damage. This call for papers ...
Alfuzosin is contraindicated in patients with a hypersensitivity to alfuzosin or other quinazolones. Alfuzosin should be used cautiously in patients who are predisposed to hypotension, including ...
3 Interdepartmental Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy Blau syndrome (BS) and early-onset ...
In a report, Philippine National Police-Drug Enforcement Group (PDEG) chief Brig. Gen. Eleazar Matta said… Read More ...